Publications by authors named "Michael-John Devlin"

Claim this Profile
P
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial.
Rebecca Kristeleit, Michael-John Devlin, Andrew Clamp, Charlie Gourley, René Roux

JAMA Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.
Karim H El-Shakankery, Joanna Kefas, Kieran Palmer, Andrew Houston, Uma Mukherjee, Michael John Devlin

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic testing in high-grade serous ovarian cancer: current options and future development.
Michael-John Devlin, Rowan Miller

Int J Gynecol Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparity in the era of personalized medicine for epithelial ovarian cancer.
Michael-John Devlin, Rowan E Miller

Ther Adv Med Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tumor Microenvironment of Clear-Cell Ovarian Cancer.
Michael-John Devlin, Rowan Miller, Florian Laforets, Panoraia Kotantaki, Dale W Garsed

Cancer Immunol Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
R Wendel Naumann, Antoine Hollebecque, Tim Meyer, Michael-John Devlin, Ana Oaknin

J Clin Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibition in Head and Neck Cancer.
Martin David Forster, Michael-John Devlin

Front Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis